According to a new report from Intel Market Research, the global Nectin-4 ADC Innovative Drugs market was valued at USD 1.55 billion in 2025 and is projected to reach USD 2.90 billion by 2034, growing at a robust CAGR of 9.2% during the forecast period (2026–2034). This growth is propelled by rising demand for precision oncology treatments, increasing prevalence of Nectin-4-expressing...